Scholarly Index
Mario Castro
Nova Medical (United States); 40,726 total citations; 596 total publications; best world rank #36
Nova Medical (United States)
40,726Total citations
596Total publications
95H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Asthma and respiratory diseases | Lifetime | 81 | US 31 | 99.74 |
| Respiratory and Cough-Related Research | Lifetime | 46 | US 15 | 99.64 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 187 | US 67 | 99.21 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 92 | US 33 | 99.06 |
| IL-33, ST2, and ILC Pathways | Lifetime | 98 | US 49 | 98.96 |
| Allergic Rhinitis and Sensitization | Lifetime | 888 | US 248 | 96.79 |
| Asthma and respiratory diseases | 2021-2025 | 39 | US 13 | 99.46 |
| Respiratory and Cough-Related Research | 2021-2025 | 36 | US 8 | 98.67 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 38 | US 15 | 97.05 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 47 | US 11 | 96.94 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 406 | US 96 | 95.11 |
| Eosinophilic Esophagitis | 2021-2025 | 383 | US 139 | 92.10 |
| Pharmaceutical studies and practices | 2021-2025 | 279 | US 98 | 87.41 |